Serum CGRP in migraine patients using erenumab as preventive treatment

AIM: Serum levels of Calcitonin Gene-Related Peptide (CGRP)-like immunoreactivity (CGRP-LI) in migraine patients before and after starting treatment with erenumab were measured to evaluate the association with clinical treatment response. METHODS: Blood samples were collected from the cubital fossa...

Descripción completa

Detalles Bibliográficos
Autores principales: de Vries Lentsch, Simone, Garrelds, Ingrid M., Danser, A. H. Jan, Terwindt, Gisela M., MaassenVanDenBrink, Antoinette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464612/
https://www.ncbi.nlm.nih.gov/pubmed/36089587
http://dx.doi.org/10.1186/s10194-022-01483-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464612/
https://www.ncbi.nlm.nih.gov/pubmed/36089587
http://dx.doi.org/10.1186/s10194-022-01483-z

Ejemplares similares